In a large study of Aleskandarany and coworkers, a cadherin switch was more frequently detected in triple negative and human epidermal growth factor receptor (HER)2-positive subtypes of invasive nonluminal breast cancer than in the luminal subtype. This evidence concerns the gene CDH17 and breast carcinoma.